期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
PD-1 inhibitor plus anlotinib for metastatic castration-resistant prostate cancer: a real-world study
1
作者 Xin-Xing Du yan-hao dong +13 位作者 Han-Jing Zhu Xiao-Chen Fei Yi-Ming Gong Bin-Bin Xia Fan Wu Jia-Yi Wang Jia-Zhou Liu Lian-Cheng Fan Yan-Qing Wang Liang dong Yin-Jie Zhu Jia-Hua Pan Bai-Jun dong Wei Xue 《Asian Journal of Andrology》 SCIE CAS CSCD 2023年第2期179-183,共5页
Management and treatment of terminal metastatic castration-resistant prostate cancer(mCRPC)remains heavily debated.We sought to investigate the efficacy of programmed cell death 1(PD-1)inhibitor plus anlotinib as a po... Management and treatment of terminal metastatic castration-resistant prostate cancer(mCRPC)remains heavily debated.We sought to investigate the efficacy of programmed cell death 1(PD-1)inhibitor plus anlotinib as a potential solution for terminal mCRPC and further evaluate the association of genomic characteristics with efficacy outcomes.We conducted a retrospective real-world study of 25 mCRPC patients who received PD-1 inhibitor plus anlotinib after the progression to standard treatments.The clinical information was extracted from the electronic medical records and 22 patients had targeted circulating tumor DNA(ctDNA)next-generation sequencing.Statistical analysis showed that 6(24.0%)patients experienced prostate-specific antigen(PSA)response and 11(44.0%)patients experienced PSA reduction.The relationship between ctDNA findings and outcomes was also analyzed.DNA-damage repair(DDR)pathways and homologous recombination repair(HRR)pathway defects indicated a comparatively longer PSA-progressionfree survival(PSA-PFS;2.5 months vs 1.2 months,P=0.027;3.3 months vs 1.2 months,P=0.017;respectively).This study introduces the PD-1 inhibitor plus anlotinib as a late-line therapeutic strategy for terminal mCRPC.PD-1 inhibitor plus anlotinib may be a new treatment choice for terminal mCRPC patients with DDR or HRR pathway defects and requires further investigation. 展开更多
关键词 anlotinib CTDNA immune checkpoint inhibitor programmed cell death-1 inhibitor prostate cancer
原文传递
Numerical calculations Of effective thermal conductivity of porous ceramics by image-based finite element method
2
作者 yan-hao dong Chang-An WANG +1 位作者 Liang-Fa HU Jun ZHOU 《Frontiers of Materials Science》 SCIE CSCD 2012年第1期79-86,共8页
The effective thermal conductivity of heterogeneous or composite materials is an essential physical parameter of materials selection and design for specific functions in science and engineering. The effective thermal ... The effective thermal conductivity of heterogeneous or composite materials is an essential physical parameter of materials selection and design for specific functions in science and engineering. The effective thermal conductivity is heavily relied on the fraction and spatial distribution of each phase. In this work, image- based finite element method (FEM) was used to calculate the effective thermal conductivity of porous ceramics with different pore structures. Compared with former theoretical models such as effective media theory (EMT) equation and parallel model, image-based FEM can be applied to a large variety of material systems with a relatively steady deviation. The deviation of image-based FEM computation mainly comes from the difference between the two dimensional (2D) image and the three dimensional (3D) structure of the real system, and an experiment was carried out to confirm this assumption. Factors influencing 2D and 3D effective thermal conductivities were studied by FEM to illustrate the accuracy and application conditions of image-based FEM. 展开更多
关键词 thermal conductivity image-based FEM porous ceramic two-phasematerial
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部